• LOGIN
    Login with username and password
Repository logo

BORIS Portal

Bern Open Repository and Information System

  • Publications
  • Projects
  • Funding
  • Research Data
  • Organizations
  • Researchers
  • LOGIN
    Login with username and password
Repository logo
Unibern.ch
  1. Home
  2. Publications
  3. Meperidine and skin surface warming additively reduce the shivering threshold: a volunteer study
 

Meperidine and skin surface warming additively reduce the shivering threshold: a volunteer study

Options
  • Details
BORIS DOI
10.7892/boris.24564
Date of Publication
2007
Publication Type
Article
Division/Institute

Universitätsklinik fü...

Contributor
Kimberger, Oliver
Universitätsklinik für Anästhesiologie und Schmerztherapie
Ali, Syed Z.
Universitätsklinik für Anästhesiologie und Schmerztherapie
Markstaller, Monica
Universitätsklinik für Anästhesiologie und Schmerztherapie
Zmoos, Sandra
Lauber, Rolf
Universitätsklinik für Anästhesiologie und Schmerztherapie
Hunkeler, Corinne
Universitätsklinik für Anästhesiologie und Schmerztherapie
Kurz, Andrea
Universitätsklinik für Anästhesiologie und Schmerztherapie
Series
Critical care
ISSN or ISBN (if monograph)
1364-8535
Publisher
BioMed Central
Language
English
Publisher DOI
10.1186/cc5709
PubMed ID
17316456
Description
INTRODUCTION: Mild therapeutic hypothermia has been shown to improve outcome for patients after cardiac arrest and may be beneficial for ischaemic stroke and myocardial ischaemia patients. However, in the awake patient, even a small decrease of core temperature provokes vigorous autonomic reactions-vasoconstriction and shivering-which both inhibit efficient core cooling. Meperidine and skin warming each linearly lower vasoconstriction and shivering thresholds. We tested whether a combination of skin warming and a medium dose of meperidine additively would reduce the shivering threshold to below 34 degrees C without producing significant sedation or respiratory depression. METHODS: Eight healthy volunteers participated on four study days: (1) control, (2) skin warming (with forced air and warming mattress), (3) meperidine (target plasma level: 0.9 mug/ml), and (4) skin warming plus meperidine (target plasma level: 0.9 mug/ml). Volunteers were cooled with 4 degrees C cold Ringer lactate infused over a central venous catheter (rate asymptotically equal to 2.4 degrees C/hour core temperature drop). Shivering threshold was identified by an increase of oxygen consumption (+20% of baseline). Sedation was assessed with the Observer's Assessment of Alertness/Sedation scale. RESULTS: Control shivering threshold was 35.5 degrees C +/- 0.2 degrees C. Skin warming reduced the shivering threshold to 34.9 degrees C +/- 0.5 degrees C (p = 0.01). Meperidine reduced the shivering threshold to 34.2 degrees C +/- 0.3 degrees C (p < 0.01). The combination of meperidine and skin warming reduced the shivering threshold to 33.8 degrees C +/- 0.2 degrees C (p < 0.01). There were no synergistic or antagonistic effects of meperidine and skin warming (p = 0.59). Only very mild sedation occurred on meperidine days. CONCLUSION: A combination of meperidine and skin surface warming reduced the shivering threshold to 33.8 degrees C +/- 0.2 degrees C via an additive interaction and produced only very mild sedation and no respiratory toxicity.
Handle
https://boris-portal.unibe.ch/handle/20.500.12422/98182
Show full item
File(s)
FileFile TypeFormatSizeLicensePublisher/Copright statementContent
4.pdftextAdobe PDF171.86 KBAttribution (CC BY 4.0)publishedOpen
BORIS Portal
Bern Open Repository and Information System
Build: 396f6f [24.09. 11:22]
Explore
  • Projects
  • Funding
  • Publications
  • Research Data
  • Organizations
  • Researchers
More
  • About BORIS Portal
  • Send Feedback
  • Cookie settings
  • Service Policy
Follow us on
  • Mastodon
  • YouTube
  • LinkedIn
UniBe logo